SubHero Banner
Text

Hulio® (adalimumab-fkjp) – New biosimilar approval

July 6, 2020 - The FDA approved Mylan’s Hulio (adalimumab-fkjp), a biosimilar to AbbVie’s Humira® (adalimumab).

Download PDF

Text